Incentive Opportunity Sample Clauses

Incentive Opportunity. BONUS AS % OF SALARY ----------- THRESHOLD TARGET MAXIMUM --------- ------ ------- 15% 25% 50%
Sample 1Sample 2Sample 3See All (7)
AutoNDA by SimpleDocs
Incentive Opportunity. Subject to the terms of this Agreement, Employee shall be eligible to participate in the Employer’s incentive compensation plan, as approved and administered by the Compensation/Nominating Committee of the Board (“Compensation Committee”), and applicable to similarly situated executives of subsidiary banking institutions of Heartland.
Sample 1Sample 2
Incentive Opportunity. Executive will be entitled to receive restricted share units (“RSUs”) payable in cash, subject to conversion to shares on approval by shareholders of a revised Equity incentive Plan, under Enterprise Value Award Plan subject to the following terms and conditions over the effective term of the Employment Agreement (and as extended pursuant to Item 2.5 below):
Sample 1
Incentive Opportunity. CIG will offer an incentive plan that, when taken in the aggregate from a performance objective setting and planning perspective, is substantially similar to that under your MACOM Japan terms of employment. The details of this incentive plan will be announced to you in May 2018.
Sample 1
Incentive Opportunity. For each full fiscal year during the Employment Term, Executive shall be eligible to receive an annual incentive (the “Annual Incentive”) with a target amount of sixty percent (60%) of Executive’s Base Salary, based on the achievement of performance targets or goals to be determined by Company after consultation with Executive, and in accordance with the terms and conditions of Company’s Short Term Incentive Plan as in effect from time to time. Subject to Section 8(b), no Annual Incentive will be earned unless Executive remains employed as of the payment date for such Annual Incentive, with such payment to be made to Executive in the fiscal year following the year giving rise to the Annual Incentive. All determinations by Company regarding the satisfactory achievement of performance targets and all other conditions for the payment of any Annual Incentive shall be in the sole discretion of Company and final and binding on Executive.
Sample 1
Incentive Opportunity. The Company grants to Participant the opportunity to receive up to _________________________ of the bonus pool established by the Company under the Plan. Participant acknowledges that his entitlement, if any, to any award payments under the Plan shall be determined thereunder.
Sample 1
Incentive Opportunity. You will be eligible for a discretionary partial incentive award for your services in 2010, to be determined after year end in the normal course of incentive award determinations and payable before March 15, 2011. Tel: 000.000.0000 • Fax: 000.000.0000 xxxxxx.xxxxxx@xxxxxxxxxxxxx.xxx Bank of America, NC1-007-58-22 000 Xxxxx Xxxxx Xxxxxx, Charlotte, NC 28255 February 22, 2010 Confirmation Regarding Covenants: You are subject to certain covenants under Article 9 of the Employment Agreement, including a covenant not to compete for 12 months under section 9.1 and a nonsolicitation of employees for 24 months under section 9.3. The covenants in Article 9 apply in connection with your retirement. However, for purposes of section 9.1, you will be considered in competition with Bank of America only if you are engaged, directly or indirectly, whether as a director, officer, employee, consultant, agent or otherwise, with a business entity that is listed on Exhibit A attached hereto. Please indicate your agreement with this letter by signing the enclosed copy of this letter and returning it to my attention by no later than February 25, 2010. Please let me know if you have any questions. Sincerely, Xxxxxx Xxxxxx ACCEPTED AND AGREED TO: Feb. 23, 2010 Xxxxxxx X. Xxxx Date Exhibit A Competitive Businesses* American Express Ameriprise Financial Barclays BlackRock BNP Paribas Capital One Xxxxxxx Xxxxxx Citigroup Credit Suisse Group Deutsche Bank E*Trade Financial Fidelity GE Capital GMAC Financial Xxxxxxx Xxxxx HSBC Xxxxxxxxx & Company JPMorgan Xxxxx Xxxxxx Xxxxxxx Xxxxxx Securities Xxxxxxxxxxx Holdings Xxxxx Xxxxxxx Companies Xxxxxx Investments Xxxxxx Xxx State Street TD AMERITRADE UBS US Bancorp Wellington Management Xxxxx Fargo
Sample 1
AutoNDA by SimpleDocs
Incentive Opportunity 
Sample 1

Related to Incentive Opportunity

  • Freedom to Pursue Opportunities The Parties expressly acknowledge and agree that: (i) Sponsor and each Sponsor Director (and each Affiliate thereof) has the right to, and shall not have any duty (contractual or otherwise) to (and none of the following shall be deemed to be wrongful or improper), (x) directly or indirectly engage in the same or similar business activities or lines of business as the Parent Parties or any of their respective Subsidiaries, including those deemed to be competing with the Parent Parties or any of their respective Subsidiaries, or (y) directly or indirectly do business with any client or customer of the Parent Parties or any of their respective Subsidiaries; and (ii) in the event that Sponsor or a Sponsor Director (or any Affiliate thereof) acquires knowledge of a potential transaction or matter that may be an opportunity for the Parent Parties or any of their respective Subsidiaries and Sponsor or any other Person, Sponsor and such Sponsor Director (and any such Affiliate) shall not have any duty (contractual or otherwise) to communicate or present such opportunity to the Parent Parties or any of their respective Subsidiaries, as the case may be, and, notwithstanding any provision of this Agreement to the contrary, shall not be liable to the Parent Parties, their respective Subsidiaries or their respective Affiliates or equity holders for breach of any duty (contractual or otherwise) by reason of the fact that Sponsor or such Sponsor Director (or such Affiliate thereof), directly or indirectly, pursues or acquires such opportunity for itself, directs such opportunity to another Person, or does not present such opportunity to the Parent Parties or any of their respective Subsidiaries; provided, that any such business, activity or transaction described in this Section 4.14 is not the direct result of Sponsor, its Affiliates or a Sponsor Director using Confidential Information in violation of Section 3.3 hereof. Notwithstanding anything to the contrary contained in this Section 4.14, any Sponsor Director may be excluded, by the members of the Board who are not Sponsor Directors, from any discussion or vote on matters in accordance with a conflicts of interest policy of the Board that is adopted by the Board in good faith and is applicable to all of the members of the Board.

  • Corporate Opportunity During the Employment Period, Executive shall submit to the Board all business, commercial and investment opportunities or offers presented to Executive, or of which Executive becomes aware, at any time during the Employment Period, which opportunities relate to the business of designing, manufacturing, marketing, or selling electromechanical or electronic sensors or controls (“Corporate Opportunities”). During the Employment Period, unless approved by the Board, Executive shall not accept or pursue, directly or indirectly, any Corporate Opportunities on Executive’s own behalf.

  • Corporate Opportunities The Executive agrees that he will not take personal advantage of any business opportunities which arise during his employment with the Company Group and which may be of benefit to the Company Group. All material facts regarding such opportunities must be promptly reported by the Executive to the Board of Trustees for consideration by the Company Group.

  • Bonus Opportunity The Company shall offer each year an incentive bonus compensation plan. Such plan will include an annual bonus target amount equal to at least 50% of the Executive’s annual base salary and shall contain such additional terms as determined by the Chief Executive Officer. The amount of any bonus payable to Executive in any year shall be based upon performance targets established in advance under the bonus plan and Executive’s achievement of such performance criteria.

  • Loan Opportunities The Company on behalf of each Fund acknowledges and agrees that BTC shall have the right to decline to make any loans of Securities under any Securities Lending Agreement, to discontinue lending or to terminate any loans of Securities under any Securities Lending Agreement in its sole discretion. The Company on behalf of each Fund agrees that it shall have no claim against BTC based on, or relating to, loans made for other customers, or loan opportunities refused hereunder, whether or not BTC has made fewer or more loans for any other customer than for the Fund, and whether or not any loan for another customer, or the opportunity refused, could have resulted in loans made hereunder.

  • Annual Bonus Opportunity Your annual target bonus opportunity following the Effective Date will be 50% of your annual base salary (the “Target Bonus”). The Target Bonus shall be subject to review and may be adjusted based upon the Company’s normal performance review practices. Your actual bonuses shall be based upon achievement of performance objectives to be determined by the Board in its sole and absolute discretion. Bonuses will be paid as soon as practicable after the Board determines that such bonuses have been earned, but in no event will a bonus be paid to you after the later of (i) the fifteenth (15th) day of the third (3rd) month following the close of the Company’s fiscal year in which such bonus is earned or (ii) March 15 following the calendar year in which such bonus is earned.

  • Business Opportunities Executive agrees, while he is employed by the Company, to offer or otherwise make known or available to it, as directed by the Board of Directors of the Company and without additional compensation or consideration, any business prospects, contracts or other business opportunities that Executive may discover, find, develop or otherwise have available to Executive in the Company’s general industry and further agrees that any such prospects, contacts or other business opportunities shall be the property of the Company.

  • Other Business Opportunities The Member and any person or entity affiliated with the Member may engage in or possess an interest in other business opportunities or ventures (unconnected with the Company) of every kind and description, independently or with others, including, without limitation, businesses that may compete with the Company. Neither the Member or any person or entity affiliated with the Member shall be required to present any such business opportunity or venture to the Company, even if the opportunity is of the character that, if presented to the Company, could be taken by it. Neither the Company nor any person or entity affiliated with the Company shall have any rights in or to such business opportunities or ventures or the income or profits derived therefrom by virtue of this Agreement, notwithstanding any duty otherwise existing at law or in equity. The provisions of this Section shall apply to the Member solely in its capacity as member of the Company and shall not be deemed to modify any contract or arrangement, including, without limitation, any noncompete provisions, otherwise agreed to by the Company and the Member.

  • Opportunities During his employment with the Company, and for one year thereafter, Executive shall not take any action which might divert from the Company any opportunity learned about by him during his employment with the Company (including without limitation during the Employment Term) which would be within the scope of any of the businesses then engaged in or planned to be engaged in by the Company.

  • Targets On or before the date that is nine (9) months after the Amendment Date to Amendment No. 2 to this Agreement, LOXO shall designate six (6) Targets from Exhibit B for which research activities will be discontinued. Upon such designation, such discontinued Targets shall cease to be Targets under this Agreement, and Exhibit B shall be deemed to be updated accordingly. On or before the date that is eighteen (18) months after the Amendment Date to Amendment No. 2 to this Agreement, LOXO shall designate two (2) additional Targets from Exhibit B for which research activities will be discontinued; provided, however, that if on or before the date that is eighteen (18) months after the Amendment Date to Amendment No. 2 to this Agreement Loxo provides to Array written notice and a payment of [***] (the “Extension Payment”), Loxo will only be required to designate one (1) additional Target from Exhibit B for which research activities will be discontinued at the end of such eighteen (18) months. Upon such designation, such additional discontinued Target(s) shall cease to be Target(s) under this Agreement, and Exhibit B shall be deemed to be updated accordingly. If Loxo made the Extension Payment, then on or before the date that is [***] after the Amendment Date to Amendment No. 2 to this Agreement, Loxo shall designate one (1) additional Target from Exhibit B for which research activities will be discontinued unless Loxo provides to Array written notice and a payment of [***] (“Additive Payment”) in which case Loxo will not need to designate any more Targets from Exhibit B for discontinuation of research activities. Until such time as the eight (8) Targets (or seven (7) Targets if Loxo has made the Extension Payment and Additive Payment) have been designated for discontinuation, and notwithstanding Section 8.2.1 to the contrary, Loxo shall only have the right, at its discretion, to file provisional patent applications covering the applicable Active Compounds to the Targets from Exhibit B and will not convert such provisional patent applications to a non-provisional patent application or otherwise prosecute any non-provisional patent application covering such Active Compounds. During the Discovery Program Term, Loxo may determine in its sole discretion that research activities with respect to one (1) particular Target on Exhibit B should be discontinued [***] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (for example, and without limitation, such Target has not yielded sufficient progress, or scientific literature suggests the Target is intractable or is not therapeutically relevant or for safety issues) and replaced with a different target. Upon any such determination, Loxo shall provide written notice to Array of the one (1) Target that Loxo desires to remove from Exhibit B and will include in such notification a suggested substitute for such discontinued Target. After receipt of such notice, Array will promptly inform Loxo whether, as of the date of such written notice, the addition of such suggested substitute target would not (i) violate any agreement that Array has with a Third Party; (ii) add a target that is the subject of Array’s own active and ongoing research (with existing commitment and expenditure of resources for such target), was the subject of previous significant research at Array, or is the subject of drugs in Array’s clinical development pipeline or marketed product portfolio; or (iii) add a target with respect to which Array is engaged in active, ongoing substantial negotiations (i.e., has agreed a term sheet containing material business terms) with a Third Party. If neither (i), (ii) or (iii) apply to such suggested substitute target, then the discontinued Target shall cease to be a Target, the suggested substitute target shall be deemed a Target for the purposes of this Agreement, and Exhibit B shall be deemed to be updated accordingly. If a proposed target is not available for inclusion, then the fact that Loxo proposed such target or is otherwise interested in such target (or molecules directed to such target) shall be Loxo’s Confidential Information.

Time is Money Join Law Insider Premium to draft better contracts faster.